Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

499.40
-0.3100-0.06%
Post-market: 499.400.00000.00%19:30 EDT
Volume:289.23K
Turnover:143.75M
Market Cap:11.51B
PE:-35.13
High:505.00
Open:505.00
Low:491.05
Close:499.71
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.24
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:21.98
PE(LYR):-38.86

Loading ...

Stock Track | Madrigal Pharmaceuticals Plunges 6.14% in Pre-market as Q2 Loss Widens and Expenses Surge Despite Revenue Growth

Stock Track
·
Jul 30

Madrigal Q2 FY26 Net Loss Widens to $57.9 Million; Net Sales Rise 71% to $364.3 Million

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Revenue Rises 71% on Rezdiffra Demand

Reuters
·
Jul 30

Earnings Flash (MDGL) Madrigal Pharmaceuticals Posts Q2 Net Loss $1.99 a Share, vs. FactSet Est of $2.68 Loss

MT Newswires Live
·
Jul 30

Madrigal Pharmaceuticals Q2 EPS $(1.99) Beats $(2.50) Estimate, Sales $364.252M Beat $353.178M Estimate

Benzinga Earnings
·
Jul 30

Madrigal Pharmaceuticals Q2 EPS USD -1.99

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Q2 Operating Income USD -56.308 Million

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
Jul 30

Madrigal Pharmaceuticals Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27

Madrigal Pharmaceuticals initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Madrigal Pharmaceuticals price target raised to $553 from $542 at BofA

TIPRANKS
·
Jul 22

BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542

MT Newswires Live
·
Jul 22

Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS

TIPRANKS
·
Jul 22

Madrigal Grants Inducement Equity Awards to 10 New Hires, Sets Option Strike at $550.25

Reuters
·
Jul 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 22

Exploring High Growth Tech Stocks In The US For July 2026

Simply Wall St.
·
Jul 20

Madrigal Pharmaceuticals Updates Financial Calendar with Quarterly Results Release, Webcast Scheduled

Reuters
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biogen (BIIB) and Cadrenal Therapeutics, Inc. (CVKD)

TIPRANKS
·
Jul 14